Literature DB >> 18626432

Genotyping of hepatitis C virus (HCV) in infected patients from Northeast Mexico.

Ana María Rivas-Estilla1, Paula Cordero-Pérez, Karina del Carmen Trujillo-Murillo, Javier Ramos-Jiménez, Carlos Chen-López, María de L Garza-Rodríguez, Angel Ramírez-Gutiérrez, Linda Muñoz-Espinosa.   

Abstract

UNLABELLED: Information about HCV genotypes in infected patients from different regions of Mexico is limited.
OBJECTIVE: To determine the prevalence of HCV genotypes in a group of HCV infected patients who attended a third level Hospital in Northeast of Mexico.
METHODS: Genotyping analysis was performed using the InnoLiPA-HCV genotype assay in 147 patients (65 males and 82 females, mean age 44 +/- 12 years) with positive anti-HCV antibodies and detectable HCV-RNA levels.
RESULTS: Infected individuals were more likely to be female (56%). Histological data showed that 63% of the patients had chronic hepatitis, while the remainder presented cirrhosis (37%). The most frequent HCV genotype was 1 (73%). We found the following distribution: genotype 1 (2.7%), 1a (28.6%), 1b (37.4%), 1a/1b (4.1%), 2a (1.4%), 2b (8.8%), 2c (0.7%), 2a/2c (2.7%), 3 (2%), 3a (10.2%), 4 (0.7%) and 4c (0.7%). The most frequent associated risk factor was blood transfusion (72.5%).
CONCLUSION: Prevalence of HCV genotypes in the Northeast of Mexico is similar to those reported previously in other Mexican regions and the most frequent risk factor continues being blood transfusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18626432

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  6 in total

1.  Correlation Study Between HCV Genotypes Distribution Pattern and Viral Load in a Tertiary Care Hospital in Kolkata, India.

Authors:  Debojyoti Bhattacharjee; Kheya Mukherjee; Goutam Chakroborti; Ranadeep Ghosh; Nabarun Mandal; Mohua Bose
Journal:  J Clin Diagn Res       Date:  2015-05-01

2.  A randomized controlled trial of double versus triple therapy with amantadine for genotype 1 chronic hepatitis C in Latino patients.

Authors:  Jorge Méndez-Navarro; Ruby A Chirino; Kathleen E Corey; Emmanuel C Gorospe; Hui Zheng; Segundo Morán; Jesus A Juarez; Raymond T Chung; Margarita Dehesa-Violante
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

3.  Need of righteous attitudes towards eradication of hepatitis C virus infection in Latin America.

Authors:  Arturo Panduro; Sonia Roman
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

4.  Distribution pattern of HCV genotypes & its association with viral load.

Authors:  Anita Chakravarti; Gaurav Dogra; Vikas Verma; Amit Parkash Srivastava
Journal:  Indian J Med Res       Date:  2011-03       Impact factor: 2.375

5.  Hepatitis C virus infection in blood donors from the state of Puebla, Mexico.

Authors:  Francisca Sosa-Jurado; Gerardo Santos-López; Belinda Guzmán-Flores; Julia I Ruiz-Conde; Daniel Meléndez-Mena; Martín T Vargas-Maldonado; Ygnacio Martínez-Laguna; Laura Contreras-Mioni; Verónica Vallejo-Ruiz; Julio Reyes-Leyva
Journal:  Virol J       Date:  2010-01-25       Impact factor: 4.099

6.  Hepatitis C virus genotypes and association with viral load in yazd, central province of iran.

Authors:  Hossein Hadinedoushan; Hasan Salmanroghani; Mohammad Kazem Amirbaigy; Mohsen Akhondi-Meybodi
Journal:  Hepat Mon       Date:  2014-03-03       Impact factor: 0.660

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.